These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 893363)

  • 1. In vitro effects of streptomyces protease inhibitors on human kidney renin activity.
    Overturf M; Druilhet R; Kirkendall WM
    J Biochem; 1977 May; 81(5):1579-81. PubMed ID: 893363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human plasma renin activity by pepstatin.
    Guyene TT; Devaux C; Menard J; Corvol P
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1301-6. PubMed ID: 12191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipain.
    McGowan EB; Shafiq SA; Stracher A
    Exp Neurol; 1976 Mar; 50(3):649-57. PubMed ID: 1253868
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs inhibiting the renin - angiotensin system.
    Antonaccio MJ; Cushman DW
    Fed Proc; 1981 Jun; 40(8):2275-84. PubMed ID: 6263716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new protease in hog thyroid lysosomes. II. A partial purification and characterization of a leupeptin-sensitive protease.
    Nakagawa H; Endo Y; Ohtaki S
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):390-5. PubMed ID: 7027712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of renin and their utility in physiologic studies.
    Haber E; Burton J
    Fed Proc; 1979 Dec; 38(13):2768-73. PubMed ID: 510563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Some problems in finding and in the microbiological synthesis of physiologically active compounds].
    Bezborodov AM
    Antibiotiki; 1975 Oct; 20(10):948-56. PubMed ID: 1211893
    [No Abstract]   [Full Text] [Related]  

  • 8. Ahpatinins, new acid protease inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid.
    Omura S; Imamura N; Kawakita K; Mori Y; Yamazaki Y; Masuma R; Takahashi Y; Tanaka H; Huang LY; Woodruff HB
    J Antibiot (Tokyo); 1986 Aug; 39(8):1079-85. PubMed ID: 3093433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo.
    Bolli R; Cannon RO; Speir E; Goldstein RE; Epstein SE
    J Am Coll Cardiol; 1983 Oct; 2(4):671-80. PubMed ID: 6350399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of renin and its inhibitors by detecting double-labelled peptidic substrates with an immunoassay.
    Gorris HH
    Analyst; 2013 Apr; 138(7):2104-9. PubMed ID: 23403906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new protease in hog thyroid lysosomes. I. The presence of a leupeptin-sensitive protease in the soluble fraction of thyroid lysosomes.
    Nakagawa H; Endo Y; Ohtaki S
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):383-9. PubMed ID: 7027711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corpuscles of Stannius secrete renin or an isorenin that regulates cardiovascular function in freshwater North American eels, Anguilla rostrata LeSueur.
    Butler DG; Zhang DH
    Gen Comp Endocrinol; 2001 Nov; 124(2):199-217. PubMed ID: 11703085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renin-angiotensin system inhibitors - biochemical and clinical aspects].
    Kuska J; Germakowska-Kowalik T; Pluta S
    Postepy Hig Med Dosw; 1982; 35(4):395-411. PubMed ID: 6183653
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of hemoglobin-hydrolase activity by the thiol-protease inhibitors leupeptin and antipain in adult rat liver cells in primary culture.
    Tanaka K; Ikegaki N; Ichihara A
    Biochem Biophys Res Commun; 1979 Nov; 91(1):102-7. PubMed ID: 518610
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of protease inhibitors on radiation transformation in vitro.
    Kennedy AR; Little JB
    Cancer Res; 1981 Jun; 41(6):2103-8. PubMed ID: 7237415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity.
    Wood JM; Criscione L; de Gasparo M; Bühlmayer P; Rüeger H; Stanton JL; Jupp RA; Kay J
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):221-6. PubMed ID: 2476594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic interruption of the renin-angiotensin system and the kidney: differential responses to angiotensin-converting enzyme and renin inhibition.
    Hollenberg NK
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S239-42. PubMed ID: 9892171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renin inhibition by peptides and pseudo-peptides].
    Corvol P
    Nephrologie; 1989; 10(2):65-71. PubMed ID: 2677816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteases and antiproteases in the progression of chronic renal insufficiency lesions. The role of the tissue renin-angiotensin system and the renin receptor].
    Nguyen G; Burcklé C; Sraer JD
    J Soc Biol; 2002; 196(4):281-4. PubMed ID: 12645296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pepstatin inhibition of rat myocardial acid protease.
    Hokins BE; Smith TW
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():439-43. PubMed ID: 1031998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.